Tags

Type your tag names separated by a space and hit enter

Serum brain-derived neurotrophic factor levels in conversion disorder: Comparative study with depression.
Psychiatry Clin Neurosci. 2007 Oct; 61(5):571-3.PC

Abstract

The aim of the present study was to compare serum brain-derived neurotrophic factor (BDNF) levels of patients with major depressive disorder (MDD) and conversion disorder (CD). Serum BDNF levels were measured in the following three groups: 15 CD patients without any comorbid diagnosis of psychiatric disorder, 24 patients with MDD, and 26 healthy subjects without any psychiatric diagnosis or psychiatric treatment. The serum BDNF level of the healthy control group (31.4 +/- 8.8 ng/mL) was statistically higher than the level of the MDD group (21.2 +/- 11.3 ng/mL) and the CD group (24.3 +/- 9.0 ng/mL; P = 0.008). This suggests that BDNF level may play a similar role in the pathophysiology of MDD and CD.

Links

Aggregator Full Text

Authors+Show Affiliations

Deveci A
Department of Psychiatry, Celal Bayar University School of Medicine, Manisa, Turkey. artuner.d@superonline.com
Aydemir O
No affiliation info available
Taskin O
No affiliation info available
Taneli F
No affiliation info available
Esen-Danaci A
No affiliation info available

MeSH

AdolescentAdultBiomarkersBrain-Derived Neurotrophic FactorConversion DisorderDepressive Disorder, MajorFemaleHumansMaleMiddle AgedPersonality InventoryReference ValuesStress, Psychological

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17875039

Citation

Deveci, Artuner, et al. "Serum Brain-derived Neurotrophic Factor Levels in Conversion Disorder: Comparative Study With Depression." Psychiatry and Clinical Neurosciences, vol. 61, no. 5, 2007, pp. 571-3.
Deveci A, Aydemir O, Taskin O, et al. Serum brain-derived neurotrophic factor levels in conversion disorder: Comparative study with depression. Psychiatry Clin Neurosci. 2007;61(5):571-3.
Deveci, A., Aydemir, O., Taskin, O., Taneli, F., & Esen-Danaci, A. (2007). Serum brain-derived neurotrophic factor levels in conversion disorder: Comparative study with depression. Psychiatry and Clinical Neurosciences, 61(5), 571-3.
Deveci A, et al. Serum Brain-derived Neurotrophic Factor Levels in Conversion Disorder: Comparative Study With Depression. Psychiatry Clin Neurosci. 2007;61(5):571-3. PubMed PMID: 17875039.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Serum brain-derived neurotrophic factor levels in conversion disorder: Comparative study with depression. AU - Deveci,Artuner, AU - Aydemir,Omer, AU - Taskin,Oryal, AU - Taneli,Fatma, AU - Esen-Danaci,Aysen, PY - 2007/9/19/pubmed PY - 2007/12/22/medline PY - 2007/9/19/entrez SP - 571 EP - 3 JF - Psychiatry and clinical neurosciences JO - Psychiatry Clin Neurosci VL - 61 IS - 5 N2 - The aim of the present study was to compare serum brain-derived neurotrophic factor (BDNF) levels of patients with major depressive disorder (MDD) and conversion disorder (CD). Serum BDNF levels were measured in the following three groups: 15 CD patients without any comorbid diagnosis of psychiatric disorder, 24 patients with MDD, and 26 healthy subjects without any psychiatric diagnosis or psychiatric treatment. The serum BDNF level of the healthy control group (31.4 +/- 8.8 ng/mL) was statistically higher than the level of the MDD group (21.2 +/- 11.3 ng/mL) and the CD group (24.3 +/- 9.0 ng/mL; P = 0.008). This suggests that BDNF level may play a similar role in the pathophysiology of MDD and CD. SN - 1323-1316 UR - https://www.unboundmedicine.com/medline/citation/17875039/Serum_brain_derived_neurotrophic_factor_levels_in_conversion_disorder:_Comparative_study_with_depression_ L2 - https://doi.org/10.1111/j.1440-1819.2007.01710.x DB - PRIME DP - Unbound Medicine ER -